🇺🇸Medical scientist seeking solutions to inequalities in healthcare, substance use treatment and integration of cannabis and psychedelics into wellness maintenance, patient-centered, innovative and cost-effective models of care. Recent featured presentations: Global Conf on Cannabis and Cannabidiol, June 3rd, 2019, “Cannabinoid therapeutics for pain and OUDs-Challenges and Solutions;” 10-26-21 "Integrating MH & SA Care into Wellness-Oriented Care," plenary presented at 2021 IPAC LVNV. Presentations will soon be available through the IPA online Learning System. David G Ostrow MD PhD LFAPA on LinkedIn. Not on Twitter, Facebook or Instagram. The Community-Based Clinical Cannabis Research & Evaluation Network (CBCCERN) is now an affiliate of the IPA and their Compassion Clinic Network. We are implementing the observational study of patients starting plant-based Rx's for pain, opioid use disorders, PTSD & depression. This database will permit comparison of cannabinoid & psychedelic Rx eith FDA-approved therapies, thus contributing harm reduction interventions to ending the opioid OD epidemic. www.DavidOstrow.consulting and CBCCERN.net websites are under construction and the CBCCERN -IPA Advisory Board is being assembled (volunteers needed!). PhD thesis: "Subcellular Organization of phospholipid and mitochondrial membrane biosynthesis." Neuropharm post-doc: "RBC Membrane ion transport markers of affective illness." Board certified in Psychiatry, Addiction & Cannabinoid Medicine. Co-founder of 1st gay community-based clinic, the Howard Brown Clinic of Chicago, led first Hep B vaccine trials & founding PI of the Multicenter AIDS Cohort Study (the MACS), the largest & still ongoing study of the natural and treated history of HIV. MACS Bibliography and publicly available datasets available through the Johns Hopkins Epidemiology website.